Analystreport

Millendo Therapeutics Inc (NASDAQ: MLND) had its price target lowered by analysts at Roth Capital from to .

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report